4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-338637
Chief Development Officer sold 3,700 shares at $113.12 ($418,562)
- Chief Development Officer acquired 3,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-08-04 | Option exercise 10b5-1 | +3,700 | $21.65 | $80,105 | 7,685 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2026-08-04 | Sale 10b5-1 | −3,700 | $113.12 | $418,562 | 3,985 | D: show line 2 in the form |
| Open-market sales · 3,700 sh · avg $113.12 · $418,562 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-08-04 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,700 | 126,300 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…